Re: AHA late breaking abstract
posted on
Nov 10, 2019 04:15PM
Yes, this is correct. The trial will have been accepted for presentation on the basis of its design, conduct, and importance. It was well designed (approved by the FDA); it was well conducted; and the results are very important, clinically and scientifically, whether positive or negative.